scPharmaceuticals Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update
Resubmission of FURSOCIX® with the U.S. Food and Drug Administration (FDA) by year-end 2019 Balance sheet remains strong with over […]
Resubmission of FURSOCIX® with the U.S. Food and Drug Administration (FDA) by year-end 2019 Balance sheet remains strong with over […]
Sustained anti-cholestatic and anti-inflammatory effects observed with no worsening of pruritus through 52 weeks Results highlight the potential for seladelpar […]
SHENZHEN, China, Nov. 13, 2018 (GLOBE NEWSWIRE) — Taoping Inc. (NASDAQ: TAOP), a leading provider of internet-based ad distribution and […]
MIAMI and LAS VEGAS, Nov. 13, 2018 (GLOBE NEWSWIRE) — Whether you need to make a simple phone call or […]
– Company to Host Conference Call and Webcast Today at 8:30 a.m. EST – – Announces patient enrollment completed in […]
During the quarter, announced updated Fabry clinical data, acceptance of Clinical Trial Application for Gaucher, and continued platform optimization CAMBRIDGE, […]
On Track to Submit First IND for RTX-134 in Q1 2019 CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — Rubius […]
Additional positive data from Phase 2b trial further support RTB101’s potential in reducing the incidence of respiratory tract infections (RTIs) […]
FREMONT, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world’s […]
New Student Enrollments Up 19% Sequentially NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) — Aspen Group, Inc. (Nasdaq: ASPU), an […]